Department of Neuroscience, Section of Neurosurgery, Catholic University School of Medicine, Rome, Italy.
Department of Neuroscience, Section of Neurosurgery, Catholic University School of Medicine, Rome, Italy; Neurosurgery Unit, Fondazione Policlinico Universitario "Agostino Gemelli" - IRCCS, Rome, Italy.
J Clin Neurosci. 2021 Nov;93:106-111. doi: 10.1016/j.jocn.2021.09.022. Epub 2021 Sep 17.
Multinodular/plexiform schwannomas and neurofibromas of major nerves are rare: before surgery, differential diagnosis among these two uncommon variants is challenging. For both forms, surgical removal is recommended in case of progressive growth and worsening of neurological symptoms. Surgery has a higher risk of neurological damage than conventional schwannomas or neurofibromas. In literature, a comparison among these rare tumors is usually limited to the pathological aspect while specific surgical and clinical management indications are lacking. Cutaneous tumors of both forms arising from terminal peripheral nerves' branches might be treated by plastic surgeons while tumors of major nerves remain under neurosurgical competence. Here we report our recent neurosurgical experience on the matter, to furnish useful suggestions for the management of these tumors.
We analyzed the clinical, radiological, and pathological data in a consecutive case series of plexiform/multinodular nerve tumors operated at our institution in the last five years.
In our series, neurofibroma type of plexiform tumors was more frequent than schwannoma type: two sporadic plexiform-multinodular schwannomas (patients 1, and 5) and three multinodular/plexiform Neurofibromatosis familial (Neurofibromatosis 1 / NF-1) (patients 2, 3, and 4). Surgery was complex when major nerves were involved. The early outcome appeared mostly related to the pre-surgical neurological conditions and histological grading.
Although sharing some features, multinodular-plexiform schwannomas and neurofibromas have consistent differences from the clinical, surgical and pathological points of view.
多发性/丛状神经鞘瘤和神经纤维瘤是大神经的罕见病变:在手术前,这两种罕见病变之间的鉴别诊断具有挑战性。对于这两种病变,建议在进行性生长和神经症状恶化的情况下进行手术切除。手术比传统的神经鞘瘤或神经纤维瘤具有更高的神经损伤风险。在文献中,对这些罕见肿瘤的比较通常仅限于病理方面,而缺乏具体的手术和临床管理指征。两种形式的起源于末梢周围神经分支的皮肤肿瘤可能由整形外科医生治疗,而大神经的肿瘤则仍由神经外科医生治疗。在这里,我们报告了我们最近在这方面的神经外科经验,为这些肿瘤的治疗提供有用的建议。
我们分析了过去五年在我们机构接受手术治疗的连续丛状/多发性神经肿瘤的临床、放射学和病理学数据。
在我们的系列中,神经纤维瘤型丛状肿瘤比神经鞘瘤型更常见:两个散发性丛状-多发性神经鞘瘤(患者 1 和 5)和三个多发性/丛状神经纤维瘤病家族性(神经纤维瘤病 1/NF-1)(患者 2、3 和 4)。当涉及到大神经时,手术变得复杂。早期结果主要与术前的神经状况和组织学分级有关。
尽管多发性-丛状神经鞘瘤和神经纤维瘤有一些共同的特征,但从临床、手术和病理的角度来看,它们有明显的区别。